Rituximab (anti-CD20), CAS 174722-31-7

Product Description: Rituximab (anti-CD20) is an anti-CD20 chimeric monoclonal antibody used to treat certain autoimmune diseases and types of cancer[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Kamburova EG, et al. In vitro effects of rituximab on the proliferation, activation and differentiation of human B cells. Am J Transplant. 2012 Feb;12(2):341-50./[2]Manches O, et al. In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas. Blood. 2003 Feb 1;101(3):949-54./[3]Byrd JC, et al. The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction. Blood. 2002 Feb 1;99(3):1038-43.

CAS Number: 174722-31-7

Molecular Weight: 144544.44

Compound Purity: 99.00

Research Area: Cancer; Inflammation/Immunology

Solubility: 10 mM in H2O

Target: CD20

• Artikelnummer: MEXHY-P9913A-25
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P9913A-25
• Green Labware: Nein
• Verpackungseinheit: 25 mg
• Mengeneinheit: STK